Simris Alg AB
5LU
Company Profile
Business description
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
Contact
Herrestadsvagen 24A
Hammenhog276 50
SWET: +46 414445050
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
6
Stocks News & Analysis
stocks
Is AUB an opportunity after shares plunge 17%?
After a takeover bid was withdrawn shares dropped to below the pre-bid price.
stocks
Attractive ASX listed income opportunity
A high forward distribution yield may entice income investors.
stocks
Have the 3 biggest losers of the ASX 200 fallen too far?
Finding value in some of the ASX’s worst recent performers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,877.50 | 8.50 | -0.10% |
| CAC 40 | 8,082.12 | 14.88 | -0.18% |
| DAX 40 | 23,701.98 | 112.54 | 0.48% |
| Dow JONES (US) | 47,300.84 | 11.51 | 0.02% |
| FTSE 100 | 9,686.41 | 16.12 | -0.17% |
| HKSE | 26,095.05 | 61.79 | 0.24% |
| NASDAQ | 23,471.40 | 195.48 | 0.84% |
| Nikkei 225 | 49,303.45 | 0.17 | 0.00% |
| NZX 50 Index | 13,502.77 | 13.62 | 0.10% |
| S&P 500 | 6,839.08 | 26.45 | 0.39% |
| S&P/ASX 200 | 8,579.70 | 7.60 | -0.09% |
| SSE Composite Index | 3,897.71 | 16.29 | -0.42% |